Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy

Ramon Barajas, Soonmee Cha

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Glioma are the most common supra-tentorial brain tumor in the USA with an estimated annual incidence of 17,000 new cases per year. Dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MRI noninvasively characterizes tumor biology allowing for the diagnosis and therapeutic monitoring of glioma. This MRI technique utilizes the rapid changes in signal intensity caused by a rapid intravascular bolus of paramagnetic contrast agent to calculate physiologic perfusion metrics. DSC perfusion MRI has increasingly become an integrated part of glioma imaging. The specific aim of this article is to review the benefits of DSC perfusion MRI in the therapy of glioma.

Original languageEnglish (US)
Pages (from-to)407-419
Number of pages13
JournalCNS oncology
Volume3
Issue number6
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Glioma
Perfusion
Therapeutics
Brain Neoplasms
Contrast Media
Incidence
Neoplasms

Keywords

  • cerebral blood volume
  • dynamic susceptibility-weighted contrast-enhanced perfusion MRI
  • glioblastoma
  • glioma
  • imaging genomics
  • metastasis
  • molecular imaging
  • peak height
  • percentage of signal intensity recovery

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy. / Barajas, Ramon; Cha, Soonmee.

In: CNS oncology, Vol. 3, No. 6, 01.11.2014, p. 407-419.

Research output: Contribution to journalArticle

@article{e7069d4ee29b4739991b90717a6d048c,
title = "Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy",
abstract = "Glioma are the most common supra-tentorial brain tumor in the USA with an estimated annual incidence of 17,000 new cases per year. Dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MRI noninvasively characterizes tumor biology allowing for the diagnosis and therapeutic monitoring of glioma. This MRI technique utilizes the rapid changes in signal intensity caused by a rapid intravascular bolus of paramagnetic contrast agent to calculate physiologic perfusion metrics. DSC perfusion MRI has increasingly become an integrated part of glioma imaging. The specific aim of this article is to review the benefits of DSC perfusion MRI in the therapy of glioma.",
keywords = "cerebral blood volume, dynamic susceptibility-weighted contrast-enhanced perfusion MRI, glioblastoma, glioma, imaging genomics, metastasis, molecular imaging, peak height, percentage of signal intensity recovery",
author = "Ramon Barajas and Soonmee Cha",
year = "2014",
month = "11",
day = "1",
doi = "10.2217/cns.14.44",
language = "English (US)",
volume = "3",
pages = "407--419",
journal = "CNS oncology",
issn = "2045-0915",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Benefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy

AU - Barajas, Ramon

AU - Cha, Soonmee

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Glioma are the most common supra-tentorial brain tumor in the USA with an estimated annual incidence of 17,000 new cases per year. Dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MRI noninvasively characterizes tumor biology allowing for the diagnosis and therapeutic monitoring of glioma. This MRI technique utilizes the rapid changes in signal intensity caused by a rapid intravascular bolus of paramagnetic contrast agent to calculate physiologic perfusion metrics. DSC perfusion MRI has increasingly become an integrated part of glioma imaging. The specific aim of this article is to review the benefits of DSC perfusion MRI in the therapy of glioma.

AB - Glioma are the most common supra-tentorial brain tumor in the USA with an estimated annual incidence of 17,000 new cases per year. Dynamic susceptibility-weighted contrast-enhanced (DSC) perfusion MRI noninvasively characterizes tumor biology allowing for the diagnosis and therapeutic monitoring of glioma. This MRI technique utilizes the rapid changes in signal intensity caused by a rapid intravascular bolus of paramagnetic contrast agent to calculate physiologic perfusion metrics. DSC perfusion MRI has increasingly become an integrated part of glioma imaging. The specific aim of this article is to review the benefits of DSC perfusion MRI in the therapy of glioma.

KW - cerebral blood volume

KW - dynamic susceptibility-weighted contrast-enhanced perfusion MRI

KW - glioblastoma

KW - glioma

KW - imaging genomics

KW - metastasis

KW - molecular imaging

KW - peak height

KW - percentage of signal intensity recovery

UR - http://www.scopus.com/inward/record.url?scp=84964313773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964313773&partnerID=8YFLogxK

U2 - 10.2217/cns.14.44

DO - 10.2217/cns.14.44

M3 - Article

C2 - 25438812

AN - SCOPUS:84964313773

VL - 3

SP - 407

EP - 419

JO - CNS oncology

JF - CNS oncology

SN - 2045-0915

IS - 6

ER -